Repeated Pulses of Methyl-Prednisolone in Adults Hospitalized With COVID-19 Pneumonia and Acute Respiratory Distress Syndrome: A Preliminary Before-After Study (CortiCOVID Study)
CONCLUSIONS: In patients with severe pneumonia due to COVID-19, the administration of methylprednisolone pulses was associated with a lower rate of OTI and/or death and a shorter hospitalization episode.PMID:38620829 | PMC:PMC7977067 | DOI:10.1016/j.opresp.2021.100086
Source: Respiratory Care - Category: Respiratory Medicine Authors: Michelle Espinosa-Solano Demetrio Gonzalez-Vergara Marta Ferrer-Galvan Maria Isabel Asensio-Cruz Jose M Lomas Cristina Roca-Oporto Maria Dolores Navarro-Amuedo Maria Paniagua-Garcia Cesar Sotomayor Nuria Espinosa Manuel Garcia-Gutierrez Jose Molina Gil-Be Source Type: research
More News: Antiviral Therapy | Coronavirus | Corticosteroid Therapy | COVID-19 | Methylprednisolone | Pneumonia | Prednisolone | Respiratory Medicine | Study